非インスリン糖尿病治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Non-insulin Diabetes Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03462 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、非インスリン糖尿病治療薬の世界市場について調査・分析し、非インスリン糖尿病治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（DPP4阻害剤、GLP-1アゴニスト、SGLT2阻害剤）、用途別（病院薬局、小売薬局、オンライン薬局、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の非インスリン糖尿病治療薬市場動向 ・主要企業別マーケットシェア ・非インスリン糖尿病治療薬の種類別市場規模2014-2019 （DPP4阻害剤、GLP-1アゴニスト、SGLT2阻害剤） ・非インスリン糖尿病治療薬の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局、その他） ・非インスリン糖尿病治療薬の北米市場：主要企業・種類別/用途別市場規模 ・非インスリン糖尿病治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・非インスリン糖尿病治療薬の中国市場：主要企業・種類別/用途別市場規模 ・非インスリン糖尿病治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・非インスリン糖尿病治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・非インスリン糖尿病治療薬のインド市場：主要企業・種類別/用途別市場規模 ・非インスリン糖尿病治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GSK、Eli Lilly、Sumitomo Dainippon Pharma、Intarcia Therapeutics、Servier、Jiangsu Hansoh Pharmaceutical、Novo Nordisk、Emisphere、Uni-Bio Science Group、Takeda、3SBio、Merck、Dong-A Pharmaceutical、Luye Pharma Group、Eurofarma、Geropharm、Alkem Labs、SatRx、Pfizer） ・非インスリン糖尿病治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels.In 2018, the global Non-insulin Diabetes Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Non-insulin Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-insulin Diabetes Therapeutics development in United States, Europe and China.

The key players covered in this study
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer

Market segment by Type, the product can be split into
DPP4 inhibitor
GLP-1 agonist
SGLT2 inhibitor

Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-insulin Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Non-insulin Diabetes Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-insulin Diabetes Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-insulin Diabetes Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 DPP4 inhibitor
1.4.3 GLP-1 agonist
1.4.4 SGLT2 inhibitor
1.5 Market by Application
1.5.1 Global Non-insulin Diabetes Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacy
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-insulin Diabetes Therapeutics Market Size
2.2 Non-insulin Diabetes Therapeutics Growth Trends by Regions
2.2.1 Non-insulin Diabetes Therapeutics Market Size by Regions (2014-2025)
2.2.2 Non-insulin Diabetes Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-insulin Diabetes Therapeutics Market Size by Manufacturers
3.1.1 Global Non-insulin Diabetes Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-insulin Diabetes Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-insulin Diabetes Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Non-insulin Diabetes Therapeutics Key Players Head office and Area Served
3.3 Key Players Non-insulin Diabetes Therapeutics Product/Solution/Service
3.4 Date of Enter into Non-insulin Diabetes Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019)
4.2 Global Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Non-insulin Diabetes Therapeutics Market Size (2014-2019)
5.2 Non-insulin Diabetes Therapeutics Key Players in United States
5.3 United States Non-insulin Diabetes Therapeutics Market Size by Type
5.4 United States Non-insulin Diabetes Therapeutics Market Size by Application

6 Europe
6.1 Europe Non-insulin Diabetes Therapeutics Market Size (2014-2019)
6.2 Non-insulin Diabetes Therapeutics Key Players in Europe
6.3 Europe Non-insulin Diabetes Therapeutics Market Size by Type
6.4 Europe Non-insulin Diabetes Therapeutics Market Size by Application

7 China
7.1 China Non-insulin Diabetes Therapeutics Market Size (2014-2019)
7.2 Non-insulin Diabetes Therapeutics Key Players in China
7.3 China Non-insulin Diabetes Therapeutics Market Size by Type
7.4 China Non-insulin Diabetes Therapeutics Market Size by Application

8 Japan
8.1 Japan Non-insulin Diabetes Therapeutics Market Size (2014-2019)
8.2 Non-insulin Diabetes Therapeutics Key Players in Japan
8.3 Japan Non-insulin Diabetes Therapeutics Market Size by Type
8.4 Japan Non-insulin Diabetes Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-insulin Diabetes Therapeutics Market Size (2014-2019)
9.2 Non-insulin Diabetes Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Non-insulin Diabetes Therapeutics Market Size by Type
9.4 Southeast Asia Non-insulin Diabetes Therapeutics Market Size by Application

10 India
10.1 India Non-insulin Diabetes Therapeutics Market Size (2014-2019)
10.2 Non-insulin Diabetes Therapeutics Key Players in India
10.3 India Non-insulin Diabetes Therapeutics Market Size by Type
10.4 India Non-insulin Diabetes Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Non-insulin Diabetes Therapeutics Market Size (2014-2019)
11.2 Non-insulin Diabetes Therapeutics Key Players in Central & South America
11.3 Central & South America Non-insulin Diabetes Therapeutics Market Size by Type
11.4 Central & South America Non-insulin Diabetes Therapeutics Market Size by Application

12 International Players Profiles
12.1 GSK
12.1.1 GSK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-insulin Diabetes Therapeutics Introduction
12.1.4 GSK Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.1.5 GSK Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-insulin Diabetes Therapeutics Introduction
12.2.4 Eli Lilly Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Sumitomo Dainippon Pharma
12.3.1 Sumitomo Dainippon Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-insulin Diabetes Therapeutics Introduction
12.3.4 Sumitomo Dainippon Pharma Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.3.5 Sumitomo Dainippon Pharma Recent Development
12.4 Intarcia Therapeutics
12.4.1 Intarcia Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-insulin Diabetes Therapeutics Introduction
12.4.4 Intarcia Therapeutics Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.4.5 Intarcia Therapeutics Recent Development
12.5 Servier
12.5.1 Servier Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-insulin Diabetes Therapeutics Introduction
12.5.4 Servier Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.5.5 Servier Recent Development
12.6 Jiangsu Hansoh Pharmaceutical
12.6.1 Jiangsu Hansoh Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-insulin Diabetes Therapeutics Introduction
12.6.4 Jiangsu Hansoh Pharmaceutical Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.6.5 Jiangsu Hansoh Pharmaceutical Recent Development
12.7 Novo Nordisk
12.7.1 Novo Nordisk Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-insulin Diabetes Therapeutics Introduction
12.7.4 Novo Nordisk Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.7.5 Novo Nordisk Recent Development
12.8 Emisphere
12.8.1 Emisphere Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-insulin Diabetes Therapeutics Introduction
12.8.4 Emisphere Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.8.5 Emisphere Recent Development
12.9 Uni-Bio Science Group
12.9.1 Uni-Bio Science Group Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-insulin Diabetes Therapeutics Introduction
12.9.4 Uni-Bio Science Group Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.9.5 Uni-Bio Science Group Recent Development
12.10 Takeda
12.10.1 Takeda Company Details
12.10.2 Company Description and Business Overview
12.10.3 Non-insulin Diabetes Therapeutics Introduction
12.10.4 Takeda Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
12.10.5 Takeda Recent Development
12.11 3SBio
12.12 Merck
12.13 Dong-A Pharmaceutical
12.14 Luye Pharma Group
12.15 Eurofarma
12.16 Geropharm
12.17 Alkem Labs
12.18 SatRx
12.19 Pfizer

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Non-insulin Diabetes Therapeutics Key Market Segments
Table Key Players Non-insulin Diabetes Therapeutics Covered
Table Global Non-insulin Diabetes Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Non-insulin Diabetes Therapeutics Market Size Market Share by Type 2014-2025
Figure DPP4 inhibitor Figures
Table Key Players of DPP4 inhibitor
Figure GLP-1 agonist Figures
Table Key Players of GLP-1 agonist
Figure SGLT2 inhibitor Figures
Table Key Players of SGLT2 inhibitor
Table Global Non-insulin Diabetes Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacy Case Studies
Figure Others Case Studies
Figure Non-insulin Diabetes Therapeutics Report Years Considered
Table Global Non-insulin Diabetes Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Non-insulin Diabetes Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-insulin Diabetes Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Non-insulin Diabetes Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Non-insulin Diabetes Therapeutics Market Share by Regions 2014-2019
Figure Global Non-insulin Diabetes Therapeutics Market Share by Regions 2014-2019
Figure Global Non-insulin Diabetes Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Non-insulin Diabetes Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Non-insulin Diabetes Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Non-insulin Diabetes Therapeutics Market Share by Manufacturers in 2018
Table Global Non-insulin Diabetes Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-insulin Diabetes Therapeutics Product/Solution/Service
Table Date of Enter into Non-insulin Diabetes Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Non-insulin Diabetes Therapeutics Market Size Share by Type (2014-2019)
Figure Global Non-insulin Diabetes Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Non-insulin Diabetes Therapeutics Market Size Share by Application (2014-2019)
Figure Global Non-insulin Diabetes Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Non-insulin Diabetes Therapeutics Revenue Market Share by Application in 2018
Figure United States Non-insulin Diabetes Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Non-insulin Diabetes Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Non-insulin Diabetes Therapeutics Market Share (2018-2019)
Table United States Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Non-insulin Diabetes Therapeutics Market Share by Type (2014-2019)
Table United States Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Non-insulin Diabetes Therapeutics Market Share by Application (2014-2019)
Figure Europe Non-insulin Diabetes Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-insulin Diabetes Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-insulin Diabetes Therapeutics Market Share (2018-2019)
Table Europe Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Non-insulin Diabetes Therapeutics Market Share by Type (2014-2019)
Table Europe Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Non-insulin Diabetes Therapeutics Market Share by Application (2014-2019)
Figure China Non-insulin Diabetes Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Non-insulin Diabetes Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Non-insulin Diabetes Therapeutics Market Share (2018-2019)
Table China Non-insulin Diabetes Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Non-insulin Diabetes Therapeutics Market Share by Type (2014-2019)
Table China Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Non-insulin Diabetes Therapeutics Market Share by Application (2014-2019)
Figure Japan Non-insulin Diabetes Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-insulin Diabetes Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-insulin Diabetes Therapeutics Market Share (2018-2019)
Table Japan Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Non-insulin Diabetes Therapeutics Market Share by Type (2014-2019)
Table Japan Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Non-insulin Diabetes Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Non-insulin Diabetes Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-insulin Diabetes Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-insulin Diabetes Therapeutics Market Share (2018-2019)
Table Southeast Asia Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Non-insulin Diabetes Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Non-insulin Diabetes Therapeutics Market Share by Application (2014-2019)
Figure India Non-insulin Diabetes Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Non-insulin Diabetes Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Non-insulin Diabetes Therapeutics Market Share (2018-2019)
Table India Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Non-insulin Diabetes Therapeutics Market Share by Type (2014-2019)
Table India Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Non-insulin Diabetes Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Non-insulin Diabetes Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-insulin Diabetes Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-insulin Diabetes Therapeutics Market Share (2018-2019)
Table Central & South America Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Non-insulin Diabetes Therapeutics Market Share by Type (2014-2019)
Table Central & South America Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Non-insulin Diabetes Therapeutics Market Share by Application (2014-2019)
Table GSK Company Details
Table GSK Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019) (Million US$)
Figure GSK Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table GSK Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Sumitomo Dainippon Pharma Company Details
Table Sumitomo Dainippon Pharma Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Sumitomo Dainippon Pharma Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Sumitomo Dainippon Pharma Recent Development
Table Intarcia Therapeutics Company Details
Table Intarcia Therapeutics Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Intarcia Therapeutics Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Intarcia Therapeutics Recent Development
Table Servier Company Details
Table Servier Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Servier Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Servier Recent Development
Table Jiangsu Hansoh Pharmaceutical Company Details
Table Jiangsu Hansoh Pharmaceutical Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Jiangsu Hansoh Pharmaceutical Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Jiangsu Hansoh Pharmaceutical Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Novo Nordisk Recent Development
Table Emisphere Company Details
Table Emisphere Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Emisphere Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Emisphere Recent Development
Table Uni-Bio Science Group Company Details
Table Uni-Bio Science Group Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Uni-Bio Science Group Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Uni-Bio Science Group Recent Development
Table Takeda Company Details
Table Takeda Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Non-insulin Diabetes Therapeutics Business (2014-2019)
Table Takeda Recent Development
Table 3SBio Company Details
Table Merck Company Details
Table Dong-A Pharmaceutical Company Details
Table Luye Pharma Group Company Details
Table Eurofarma Company Details
Table Geropharm Company Details
Table Alkem Labs Company Details
Table SatRx Company Details
Table Pfizer Company Details
Table Global Non-insulin Diabetes Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Non-insulin Diabetes Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Non-insulin Diabetes Therapeutics Market Size Share by Regions in 2025
Figure United States Non-insulin Diabetes Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-insulin Diabetes Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Non-insulin Diabetes Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-insulin Diabetes Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-insulin Diabetes Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Non-insulin Diabetes Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-insulin Diabetes Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Non-insulin Diabetes Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Non-insulin Diabetes Therapeutics Market Size by Product (2019-2025)
Figure Global Non-insulin Diabetes Therapeutics Market Size by Product in 2025
Table Global Non-insulin Diabetes Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Non-insulin Diabetes Therapeutics Market Size by Application (2019-2025)
Figure Global Non-insulin Diabetes Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---